Category Archives:

By Jeffrey Dastin PALO ALTO, California (Reuters) - Alphabet Inc's Google on Tuesday unveiled a flurry of artificial intelligence (AI) tools for its email, collaboration and cloud software, taking aim...

By Bart Biesemans and Clement Rossignol KORTRIJK, Belgium (Reuters) - Hospital food would normally rank alongside school lunches on the culinary charts but a hospital in western Belgium has broken the...

BRUSSELS (Reuters) - Microsoft on Tuesday signed a licensing deal with Ukraine-based cloud gaming provider Boosteroid that will allow the latter's users to stream Activision's Call of Duty franchise, ...

By Foo Yun Chee LUXEMBOURG (Reuters) - Qualcomm on Tuesday criticised European Union antitrust regulators over their definition of rebates given to Chinese phone makers Huawei and ZTE in the second da...

NEW YORK (Reuters) - U.S. consumer prices increased in February amid sticky rental housing costs, but economists are divided on whether rising inflation will be enough to push the Federal Reserve to h...

(Reuters) - Asset management firm Baron Capital bought stock of Charles Schwab on Monday, CNBC reported on Tuesday, aiming to buy a dip in its shares amid a meltdown in financial stocks. Shares of the...

By Elizabeth Howcroft LONDON (Reuters) - Britain's NatWest has imposed new limits on the daily and monthly amount customers can send to cryptocurrency exchanges, seeking to protect consumers from "cry...

WASHINGTON (Reuters) - Democratic U.S. Senator Elizabeth Warren on Tuesday called on Federal Reserve Chair Jerome Powell to recuse himself from an internal review of recent bank failures, saying his a...

By Erwin Seba (Reuters) - A U.S. National Labor Relations Board (NLRB) administrative law judge on Monday ordered Exxon Mobil Corp to make whole 1,800 employees at two refineries for lost earnings dur...

(Reuters) -Drugmaker Novo Nordisk said on Tuesday it would cut list prices for several insulin drugs by up to 75% in the United States, starting Jan. 1, 2024. With the move, Novo joins U.S. drugmaker ...